The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease

Thromb Haemost. 2005 Jul;94(1):224-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alleles
  • Angiography
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Atorvastatin
  • Blood Pressure
  • Coronary Artery Disease / genetics*
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrin Fibrinogen Degradation Products / biosynthesis
  • Genotype
  • Hemostasis
  • Heptanoic Acids / pharmacology*
  • Heterozygote
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Male
  • Middle Aged
  • Myocardial Infarction / genetics
  • Myocardial Infarction / pathology
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic*
  • Pyrroles / pharmacology*
  • Quinapril
  • Risk
  • Tetrahydroisoquinolines / pharmacology*
  • Time Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Fibrin Fibrinogen Degradation Products
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Tetrahydroisoquinolines
  • fibrin fragment D
  • Atorvastatin
  • Peptidyl-Dipeptidase A
  • Quinapril